Navigation Links
AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
Date:11/17/2010

ALISO VIEJO, Calif., Nov. 17, 2010 /PRNewswire-FirstCall/ -- AVANIR Pharmaceuticals, Inc. (Nasdaq: AVNR) today announced the pricing of an underwritten public offering of 20,000,000 shares of its common stock, offered at a price of $4.40 per share.  The offering is expected to close on or about November 22, 2010, subject to customary closing conditions.  In addition, AVANIR has granted the underwriters a 30-day option to purchase up to an additional 3,000,000 shares of common stock to cover over-allotments, if any.  Jefferies & Company, Inc. is acting as sole book-running manager in the offering and Canaccord Genuity Inc., Wedbush PacGrow Life Sciences, Summer Street Research Partners, and Merriman Capital are acting as co-managers for the offering.  In addition Trout Capital LLC is serving as a financial advisor to AVANIR.

Gross offering proceeds will be approximately $88,000,000, before deducting customary underwriting discounts and commissions and offering expenses. AVANIR intends to use the net proceeds from this offering for sales and marketing activities relating to its newly approved product NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate).  In addition, the proceeds may be used for further clinical, regulatory and commercial development of NUEDEXTA, as well as potential business development activities and for general working capital.

Registration statements relating to the shares of common stock issued in the offering have been filed with, and declared effective by, the Securities and Exchange Commission (the "SEC").  A final prospectus supplement relating to the offering will be filed with the SEC.  Copies of the final prospectus supplement and related prospectuses, when available, may be obtained from Equity Syndicate Prospectus Department, Jefferies & Co
'/>"/>

SOURCE AVANIR Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
2. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
3. AVANIR Pharmaceuticals to Present at the UBS Global Life Sciences Conference
4. AVANIR Pharmaceuticals Invites Investors to Fiscal 2010 Third Quarter Conference Call
5. Nautilus Neurosciences and Tribute Pharmaceuticals Announce Exclusive Canadian License for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine
6. AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
7. Vanda Pharmaceuticals Appoints Chief Financial Officer
8. Jazz Pharmaceuticals Announces Presentation at the Lazard Capital Markets Healthcare Conference on November 17
9. Transcept Pharmaceuticals Reports Third Quarter 2010 Financial Results
10. Cumberland Pharmaceuticals Reports Third Quarter 2010 Financial Results
11. Reata Pharmaceuticals to Present Data from Pivotal Phase 2b Trial in Type 2 Diabetics With Chronic Kidney Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 More than a third of reproductive-aged women enrolled ... private insurance, filled a prescription for an opioid pain medication ... week,s Morbidity and Mortality Weekly Report (MMWR). ... moderate to severe pain.  They are also found in some ...
(Date:1/23/2015)... , Jan. 23, 2015 /PRNewswire/-- Harwood Feffer LLP ( ... of directors of Advaxis, Inc. ("Advaxis" or the "Company") ... has breached its fiduciary duties to shareholders. ... an investing website reporting that Advaxis had misrepresented the ...
(Date:1/23/2015)... 23, 2015  HyGreen, Inc., a leader in hand hygiene ... RCA Medical, a subsidiary of Ascendis Health Limited, in ... Each year, hundreds of millions of patients around the ... are transmitted from patient to patient via the unwashed ...
Breaking Medicine Technology:Opioid painkillers widely prescribed among reproductive age women 2Opioid painkillers widely prescribed among reproductive age women 3Harwood Feffer LLP Announces Investigation of Advaxis, Inc. 2HyGreen Partners with RCA Medical in Johannesburg, South Africa 2
(Date:1/22/2015)... LunaDress, with its top dressmaking technologies, has been a ... is showing its latest designs of wedding dresses and launching ... company’s CEO, all the fresh new products are designed for ... to 80% off. All the clothes from LunaDress follow up ...
(Date:1/22/2015)... 2015 Woodloch Pines, an all-inclusive family ... by TripAdvisor as the number one best large hotel for ... the world for their annual Travelers’ Choice Awards. , ... The website is home to millions of unbiased and honest ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Padre Murphy's and ... supporter of Pro Player Health Alliance (PPHA). The ... Murphy's in getting everyone, including NFL greats, treated for obstructive ... the leading groups supporting the cause in the valley. The ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method ... lean muscle by up to 30lbs in less than 12 ... HealthyandFitZone.com’s Stan Stevenson, prompting an investigative review. , “Our ... scientific diet formula that allows the body to pack on ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Blue Cross and ... Minnesotans who exemplify what it means to “Live Fearless.” ... for people to share their stories about how they or ... simply inspired others by living in the moment. By telling ...
Breaking Medicine News(10 mins):Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2
... On and Expand,Transformational Approach -, NEW YORK, Dec. ... (MJFF) today announced the appointment,of Katie Hood as chief ... in September 2002, has been serving,as interim CEO since ... Foundation,s strategy of inserting itself proactively into the research,process ...
... does nothing to clear the nose, studies suggest , , ... panel of U.S. Food and Drug Administration (FDA) experts ... over-the-counter cold medicines do nothing to clear nasal congestion. ... containing 10 milligrams per dose of phenylephrine. Studies ...
... ANTONIO − The targeted therapy Herceptin helps women with ... have extra copies of chromosome 17, home to the ... cancer growth. Prior to this report, there were conflicting ... Clinic investigators who presented their findings at the San ...
... Can a tiny winged insects salivary glands really tell ... a new study by researchers at the University of Massachusetts ... degradation process associated with a form of programmed cell deathby ... , Since its initial discovery in the 1960s, programmed ...
... /PRNewswire-FirstCall/ - Neurochem,(International) Limited (Neurochem), a wholly-owned ... TSX: NRM), announces that the Committee for ... committee of the European,Medicines Agency (EMEA), has ... marketing authorization application (MAA) for eprodisate,(KIACTA(TM)) for ...
... in Information Technology ... ... Michael Long, senior,vice president, Global Services, Siemens Medical Solutions, (http://www.usa.siemens.com/healthcareit ... Computerworld,s 2008 Premier 100 IT Leaders,Program., (Logo: http://www.newscom.com/cgi-bin/prnh/20070904/SIEMENSLOGO ...
Cached Medicine News:Health News:Katie Hood Appointed Chief Executive Officer of The Michael J. Fox Foundation 2Health News:FDA Mulls Effectiveness of OTC Cold Remedies 2Health News:FDA Mulls Effectiveness of OTC Cold Remedies 3Health News:FDA Mulls Effectiveness of OTC Cold Remedies 4Health News:Herceptin helps women with multiple chromosomes containing HER2 gene, study finds 2Health News:Identification of new genes shows a complex path to cell death 2Health News:Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis 2Health News:Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis 3Health News:Siemens Medical Solutions' Michael Long Recognized as one of Computerworld's 2008 Premier 100 IT Leaders 2Health News:Siemens Medical Solutions' Michael Long Recognized as one of Computerworld's 2008 Premier 100 IT Leaders 3Health News:Siemens Medical Solutions' Michael Long Recognized as one of Computerworld's 2008 Premier 100 IT Leaders 4
... Surgical's Breakthrough in Battery Powered Orthopedic Systems., ... revolutionary new addition to the Hall® Surgical ... Battery System is the first and only ... the market. It is a full-function orthopedic ...
... the new large power ... new handpieces function as ... instruments, offering the ultimate ... versatility the industry has ...
... OBIs proprietary PolyGraft® material technology which ... that is both biologically friendly and ... of polylactide-co-glycolide, calcium sulfate and polyglycolide ... fabricated into products such as granules, ...
... Release System is a technological breakthrough in ... a minimally-invasive approach, provides significant patient benefits. ... of the wrist,creates an entry for the ... a standard video camera system, provides a ...
Medicine Products: